AOI Biosciences, Inc.
A biotechnology company developing antibody diagnostics and drug-discovery methods for difficult protein targets.
UndisclosedEquity issuance and secondary transfer
ParticipantGV
GoAhead Ventures
Activity from announced rounds
Activity in this selectionSep 30, 2026 · Sep 1, 2026
GoAhead Ventures is a Silicon Valley early-stage firm associated with managing partner Ken Mori, whom AOI identifies in its announcement.
Recorded funding activity
AOI develops antibody diagnostics and discovery methods. The recorded activity also includes Poseidon’s unmanned cargo aircraft and Multiplier’s agent systems for investment research. These are particular company financings captured under the firm’s name.
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $11M 1 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionPoseidon Aerospace
Poseidon Aerospace is developing unmanned cargo aircraft for commercial freight and defense logistics. Its Egret short-takeoff-and-landing freighter and Heron seaplane are designed to move heavy loads between small, remote or water-based operating sites without an onboard pilot.
$11MSeed
Participant